CLSD Clearside Biomedical Inc

Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye.

$5.50  -0.14 (-2.48%)
As of 10/18/2021 15:52:10 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/02/2016
Outstanding shares:  59,479,568
Average volume:  498,569
Market cap:   $340,223,129
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    185063104
ISIN:        US1850631045
Valuation   (See tab for details)
PE ratio:   -14.59
PB ratio:   17.25
PS ratio:   79.92
Return on equity:   -118.89%
Net income %:   -540.08%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy